Medicare Enrolled

Dr. Rafid Yousif, M.D.

Urology Physician · East Lansing, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1625 RAMBLEWOOD DR, East Lansing, MI 48823
5173243700
In practice since 2006 (19 years)
NPI: 1417042698 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yousif from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yousif? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yousif

Dr. Rafid Yousif is an urology physician in East Lansing, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Yousif performed 3,404 Medicare services across 2,542 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yousif received a total of $28,728 from 76 pharmaceutical and/or device companies across 556 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yousif is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 17% volume in MI $28,728 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,404
Medicare services
Top 17% in MI for urology physician
2,542
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~179 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
742 $2 $8
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
481 $7 $16
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
476 $60 $106
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
465 $80 $161
Leuprolide acetate (for depot suspension), 7.5 mg 164 $131 $1,000
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
160 $165 $327
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
141 $109 $200
Abdominal X-ray, 1 view
An X-ray image of the abdomen taken from a single angle to visualize internal structures.
110 $21 $36
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
81 $42 $91
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
76 $76 $143
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
67 $52 $129
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
66 $19 $106
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
41 $90 $187
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
34 $106 $722
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
31 $25 $36
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
31 $110 $250
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
31 $98 $154
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
27 $62 $119
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
26 $302 $1,220
Limited retroperitoneal ultrasound
A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures.
26 $41 $80
Injection, garamycin, gentamicin, up to 80 mg 22 $2 $25
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
19 $157 $389
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
17 $239 $447
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
16 $258 $623
Transurethral prostate removal with electrocautery
This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding.
16 $557 $1,162
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
15 $14 $31
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $37 $55
Complicated insertion of bladder tube 11 $59 $223
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
20.2% medium
77.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$28,728
Total received (2018-2024)
Avg $4,104/year across 7 years
Top 6% in MI for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
556
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,636 (68.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,130 (24.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,961 (6.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,520
2023
$3,435
2022
$5,481
2021
$2,737
2020
$1,532
2019
$4,949
2018
$4,075

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bayer Healthcare Pharmaceuticals Inc.
$1,961
Axonics, Inc.
$1,630
Teleflex LLC
$1,223
INTUITIVE SURGICAL, INC.
$378
Janssen Biotech, Inc.
$250
Sumitomo Pharma America, Inc.
$171
Laborie Medical Technologies Corp.
$169
ABBVIE INC.
$86
Medtronic, Inc.
$75
Dendreon Pharmaceuticals LLC
$63
SUN PHARMACEUTICAL INDUSTRIES INC.
$50
Ferring Pharmaceuticals Inc.
$48
ACCORD HEALTHCARE, INC.
$45
Astellas Pharma US Inc
$43
Olympus America Inc.
$36
Myriad Genetic Laboratories, Inc.
$34
Merck Sharp & Dohme LLC
$32
COLOPLAST CORP
$29
PROCEPT BioRobotics Corporation
$27
Agiliti Surgical, Inc.
$25
BIOPROTECT MEDICAL, INC.
$22
Blue Earth Diagnostics Limited
$21
Photocure Inc
$19
PFIZER INC.
$18
PROGENICS PHARMACEUTICALS, INC.
$18
Antares Pharma, Inc.
$17
Tolmar, Inc.
$16
AstraZeneca Pharmaceuticals LP
$14
Top 3 companies account for 73.8% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$4,084
Axonics, Inc.
$3,274
Intuitive Surgical, Inc.
$2,930
Teleflex LLC
$2,227
Medtronic USA, Inc.
$2,218
Bayer Healthcare Pharmaceuticals Inc.
$2,080
NeoTract Inc.
$1,883
Astellas Pharma US Inc
$931
Janssen Biotech, Inc.
$834
Boston Scientific Corporation
$590
Coloplast Corp
$496
PROCEPT BioRobotics Corporation
$460
Dornier MedTech America, Inc
$416
INTUITIVE SURGICAL, INC.
$378
BOSTON SCIENTIFIC CORPORATION
$335
Blue Earth Diagnostics Limited
$301
Laborie Medical Technologies Corp.
$257
UroGen Pharma, Inc.
$252
ABBVIE INC.
$250
AbbVie Inc.
$250
Sumitomo Pharma America, Inc.
$235
Myriad Genetic Laboratories, Inc.
$220
AbbVie, Inc.
$209
Axonics Modulation Technologies, Inc.
$201
PFIZER INC.
$196
SRS Medical Systems, Inc.
$184
Endo Pharmaceuticals Inc.
$178
Dendreon Pharmaceuticals LLC
$175
TOLMAR Pharmaceuticals, Inc.
$164
Olympus America Inc.
$146
Telix Pharmaceuticals
$142
Antares Pharma, Inc.
$132
Caldera Medical, Inc
$127
UROVANT SCIENCES INC
$117
Heron Therapeutics, Inc.
$115
AstraZeneca Pharmaceuticals LP
$112
Amgen Inc.
$105
Bayer HealthCare Pharmaceuticals Inc.
$102
Janssen Scientific Affairs, LLC
$96
Janssen Products, LP
$85
Cook Medical LLC
$76
Allergan, Inc.
$72
Allergan Inc.
$68
ACCORD HEALTHCARE, INC.
$65
COLOPLAST CORP
$64
Ferring Pharmaceuticals Inc.
$61
Myovant Sciences Inc.
$58
Palette Life Sciences, Inc.
$57
Ethicon US, LLC
$55
Novartis Pharmaceuticals Corporation
$51
SUN PHARMACEUTICAL INDUSTRIES INC.
$50
Augmenix, Inc.
$45
Clarus Therapeutics Inc.
$45
Merck Sharp & Dohme Corporation
$44
Sun Pharmaceutical Industries Inc.
$39
Tolmar, Inc.
$34
Merck Sharp & Dohme LLC
$32
Photocure Inc
$30
Agiliti Surgical, Inc.
$25
Baxter Healthcare
$23
BIOPROTECT MEDICAL, INC.
$22
UROGEN PHARMA, INC.
$21
Accord Healthcare, Inc.
$20
PROGENICS PHARMACEUTICALS, INC.
$18
Travere Therapeutics, Inc.
$18
GENZYME CORPORATION
$17
HealthTronics Mobile Solutions, LLC
$17
Supernus Pharmaceuticals, Inc.
$16
DENTSPLY IH AB
$14
Kowa Pharmaceuticals America, Inc.
$14
Acerus Pharmaceuticals Corporation
$13
E.R. Squibb & Sons, L.L.C.
$13
ACELL, INC.
$11
ROCHESTER MEDICAL CORPORATION
$11
AMAG Pharmaceuticals, Inc.
$11
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 35.8% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ADVANCE · AFINITOR · AMS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · ARIS · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CYSVIEW · Cook Medical Flexor · Cysview · Da Vinci Surgical System · Desara · Dornier MedTech · ECHELON FLEX Stapler · ELIGARD · ENSEAL Product Family · ERLEADA · Erleada · GEMTESA · ILLUCCIX · INTERSTIM · INTRAROSA · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Luja Coude · Lupron · Lupron Depot · MYRBETRIQ · Mobile Cryoblation Services · Myrbetriq · NGage · NOCDURNA · Natesto · Nubeqa · OPDIVO · ORGOVYX · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · PENILE & TESTICULAR RECONSTRUCTN · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · RETRACE · REZUM · ReTrace · STELARA · Seglentis · Sonablate HIFU · SpaceOAR · Spanner Prothetic Stent · SpeediCath · THROMBIN · TISSEEL · TITAN · TOVIAZ · Thiola · UROLIFT · UroCuff · UroLift · UroLift System · VESICARE · VIAGRA · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYNRELEF · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (68%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for urology physician in MI.

Looking for an urology physician in East Lansing?
Compare urology physicians in the East Lansing area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
22
Per 100K population
7.8
County median income
$64,354
Nearest hospital
BRIGHTWELL BEHAVIORAL HEALTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yousif is a clinical cardiology specialist, with above-average Medicare volume (top 17% in MI), with low-engagement industry engagement in the top 6% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yousif experienced with automated urinalysis?
Based on Medicare claims data, Dr. Yousif performed 742 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yousif receive payments from pharmaceutical companies?
Yes. Dr. Yousif received a total of $28,728 from 76 companies across 556 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yousif's costs compare to other urology physicians in East Lansing?
Dr. Yousif's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yousif) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →